CompletedNCT02418195
Blood Markers Related to Suicidal Thoughts and Ketamine Treatment
About this title
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
Read the official source — NCT02418195Medication studyAges 18–65United StatesSuicide prevention
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BirminghamSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: April 20, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 247
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02418195
- Official title
Show the full official title
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alabama at Birmingham, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 65 years.
